Crossmark

Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-660

Published Online: 2014-09-10

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kopetz, Scott

Morris, Van K

Parikh, Nila

Overman, Michael J

Jiang, Zhi-Qin

Maru, Dipen

Elvin, Paul

Gallick, Gary
License Information

License valid from 2014-09-10
More Information

Article History

Received: 22 January 2014

Accepted: 22 August 2014

First Online: 10 September 2014